139 results on '"Hagemann, Jan"'
Search Results
2. Biologikatherapie bei schwer erkrankten Patienten mit „NSAID-exacerbated respiratory disease“ und stattgehabter ASS‑Desaktivierung: Ergebnisse einer multizentrischen Studie
3. Qualitätssteigerung der Dokumentation zur Biologikatherapie der chronischen Rhinosinusitis durch digitale, strukturierte Befunderhebung und Indikationsstellung?
4. Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis
5. Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer
6. Is bilateral radiotherapy necessary for patients with unilateral squamous cell carcinoma of unknown primary of the head and neck region?
7. Current Goals of NSAID-ERD Management: Patient-Centered Approaches Involving NSAID Desensitization With and Without Biologics
8. Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
9. Avoidance measures for mite allergy—an update
10. Olfactory and gustatory disorders in COVID-19
11. Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP): Recommendations by German allergy and ORL societies AeDA and DGHNO for dupilumab, omalizumab, and mepolizumab
12. Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2—results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2)
13. Current Management of Allergic Rhinitis
14. Rhinitis allergica in storage mite allergy: Position paper of the Medical Association of German Allergists (AeDA) and the German Society for Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC)
15. Cloning Strategy for HDAC1/HDAC2 Hybrid Protein Expression in Mammalian Cells
16. Wirksamkeit und Sicherheit des Kombinations-Nasensprays Olopatadinhydrochlorid-Mometasonfuroat in der Behandlung der allergischen Rhinitis
17. Die Zukunft der Allergologie mitgestalten: das Potenzial digitaler Lösungen, open source und KI bei Patientenversorgung und Registerstudien
18. Granulomatosis with Polyangiitis in otorhinolaryngology – a case report
19. Karenzmaßnahmen bei Milbenallergie - ein Update
20. Fakten und Mythen zu Biologika bei CRSwNP
21. Author’s reply to the Letter to the Editor “The study of olfactory dysfunction in SARS-CoV-2 variants”
22. Is bilateral radiotherapy necessary for patients with unilateral squamous cell carcinoma of unknown primary of the head and neck region?
23. Gemeinsame Stellungnahme der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie (DGHNO-KHC) und des Deutschen Berufsverbandes der HNO-Ärzte (BVHNO) für ärztliches Personal in der Hals-, Nasen- und Ohrenheilkunde/Kopf- und Hals-Chirurgie zum Arbeiten in der Schwangerschaft und Stillzeit
24. Mythos Nr. 1 "Praxisbesonderheit": Was ist die Voraussetzung zur Verordnung?
25. Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making
26. Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and Neck
27. Karenzmaßnahmen bei Milbenallergie - ein Update
28. Allergen-Immuntherapie bei Hausstaubmilben-assoziierter allergischer Rhinitis: Wirksamkeit der 300 IR-Milbentablette
29. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air approach.
30. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach
31. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach
32. The ARIA-MASK-air® approach
33. Rhinitis associated with asthma is distinct from rhinitis alone: TARIA‐MeDALL hypothesis
34. Obituary: Professor Peter Valentin Tomazic, Graz, Austria.
35. Störungen des Riech- und Schmeckvermögens bei COVID-19
36. The Vitamin D Receptor–BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer
37. Dokumentation von Biologika-Therapien bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP): Dupilumab, Omalizumab und Mepolizumab
38. Reply to correspondence to ‘Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus’
39. Comparison of imaging for cervical lymph nodes after primary radio(chemo)therapy of advanced HNSCC – preliminary findings of the HN-Onkoimage-1 trial
40. Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)
41. Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer
42. Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for Chemoresistance
43. Rhinitis allergica bei Vorratsmilbenallergie
44. Die besondere Rolle von VRAC Ionenkanälen bei Chemoresistenz und Auswirkungen auf die Wirksamkeit von Cisplatin-basierter Chemotherapie
45. IsoMAG–An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
46. Rhinitis allergica in storagemite allergy: Position paper of the Medical Association of German Allergists (AeDA) and the German Society for Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC)
47. Characterization of a novel microfluidic platform for the isolation of rare single cells to enable CTC analysis from head and neck squamous cell carcinoma patients
48. Minderung der Regressgefahr beim Einsatz von Biologika gegen CRSwNP
49. Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants : a follow-up on ARIA consensus
50. IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.